Frequency of and time to insulin use in diabetic patients receiving metformin (MF) and sulfonylurea (SU) combination therapy

被引：0

|

作者：

Pietri, G

Yin, DD

Lyu, RR

机构：

来源：

DIABETES | 2005年 / 54卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A296 / A296

页数：1

相关论文

共 50 条

[21] EFFECTS OF SULFONYLUREA THERAPY ON INSULIN BINDING TO MONONUCLEAR LEUKOCYTES OF DIABETIC-PATIENTS
OLEFSKY, JM
REAVEN, GM
AMERICAN JOURNAL OF MEDICINE, 1976, 60 (01): : 89 - 95
[22] Triple therapy in type 2 diabetes (T2DM): Benefits of insulin glargine (GLAR) over rosiglitazone (RSG) added to combination therapy of sulfonylurea plus metformin (SU plus MET) in insulin-naive patients
Rosenstock, J
Sugimoto, D
Strange, P
Stewart, J
Soltes-Rak, E
Dailey, G
DIABETES, 2004, 53 : A145 - A145
[23] UKPDS - 6-YEAR TRIAL OF SULFONYLUREA, INSULIN AND METFORMIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH DIET FAILURE
CULL, CA
HOLMAN, RR
TURNER, RC
DIABETOLOGIA, 1995, 38 : A24 - A24
[24] Efficacy of Combination of Insulin Glargine with either Metformin or Sulfonylurea in Patients with Poorly Controlled Type 2 Diabetes
Chuang, Shih-Ming
Wang, Chao-Hung
Liu, Sung-Chen
Chien, Ming-Nan
Chen, Wei-Che
INTERNATIONAL JOURNAL OF GERONTOLOGY, 2020, 14 (02) : 138 - 141
[25] Addition of glargine insulin versus rosiglitazone in diabetic subjects poorly controlled on maximum dose metformin/sulfonylurea therapy
Triplitt, C
Glass, L
Miyazaki, Y
Wajcberg, E
Frantz, D
Cersosimo, E
Defronzo, RA
DIABETES, 2004, 53 : A149 - A149
[26] The use of metformin, sulfonylurea compounds and insulin and the risk of hip fractures in diabetic patients: a systematic review and meta-analysis of observational studies
Bahardoust, Mansour
Yarali, Mohsen
Donyadideh, Ghazaleh
Rahimi, Elham
Naderi, Delaram
Tehrani, Farshid Monshizadeh
Delpisheh, Ali
BMC MUSCULOSKELETAL DISORDERS, 2023, 24 (01)
[27] The use of metformin, sulfonylurea compounds and insulin and the risk of hip fractures in diabetic patients: a systematic review and meta-analysis of observational studies
Mansour Bahardoust
Mohsen Yarali
Ghazaleh Donyadideh
Elham Rahimi
Delaram Naderi
Farshid Monshizadeh Tehrani
Ali Delpisheh
BMC Musculoskeletal Disorders, 24
[28] ENERGY-EXPENDITURE IN TYPE-2 DIABETIC-PATIENTS ON METFORMIN AND SULFONYLUREA THERAPY
CHONG, PKK
JUNG, RT
RENNIE, MJ
SCRIMGEOUR, CM
DIABETIC MEDICINE, 1995, 12 (05) : 401 - 408
[29] Prevalence of edema in patients receiving combination therapy with insulin an thiazolidinedione
King, KA
Levi, VE
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (04) : 390 - 393
[30] Combination therapy with insulin glargine plus metformin but not insulin glargine plus sulfonylurea provides similar glycemic control to triple oral combination therapy in patients with type 2 diabetes uncontrolled with dual oral agent therapy
Hollander, Priscilla
Sugimoto, Danny
Vlajnic, Aleksandra
Kilo, Charles
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (08) : 1266 - 1271

← 1 2 3 4 5 →